Table 2

Outcomes of the intention-to-treat analysis, with objective sickness absence measured at 12 months and 18 months of follow-up and questionnaire data measured at baseline (T0), 6 months (T1) and 12 months (T2) of follow-up.

VariableIntervention group (n=69)Control group (n=70)β, RR, HR§ (95% CI)p Value
Objective sickness absence
0–12*
 At least one time on sick leave; N (%)56 (81.2)48 (68.6)1.18 (0.97 to 1.44)0.118
 Duration (calendar days); mean (SD)/median27.48 (44.74)/11.0050.83 (75.75)/15.00−0.62 (−1.12 to −0.11)0.017
 Frequency; mean (SD)/median2.34 (1.61)/2.002.35 (1.78)/2.00−0.01 (−0.28 to 0.26)0.963
 Time to onset of first sickness absence spell (calendar days); mean (SD)151.38 (136.99)187.37 (146.42)1.35 (0.92 to 1.99)0.129
0–18
 At least one time on sick leave; N (%)62 (89.9)56 (80.0)1.12 (0.98 to 1.29)0.154
 Duration (calendar days); mean (SD)/median45.03 (76.59)/20.5062.57 (81.89)/25.50−0.33 (−0.78 to 0.12)0.150
 Frequency; mean (SD)/median2.97 (2.09)/2.002.93 (2.17)/2.000.01 (−0.24 to 0.67)0.918
 Time to onset of first sickness absence spell (calendar days); mean (SD)177.87 (184.21)231.19 (206.57)1.34 (0.93 to 1.93)0.117
Participants with sickness absence spell(s) >28 calendar days; N (%)
 0–12*9 (13.0)17 (24.6)0.54 (0.26 to 1.12)0.127
 0–1814 (20.3)22 (31.4)0.65 (0.36 to 1.16)0.175
Depressive complaints according to Beck Depression Inventory-II (0–63); mean (SD)
 Baseline T017.03 (9.55)14.84 (8.11)
 T112.77 (10.48)16.30 (10.08)
 T212.42 (9.64)16.69 (11.04)
 T1–T0−4.41 (7.00)0.92 (7.06)−5.08 (−7.91 to −2.25)0.001
 T2–T0−3.79 (8.45)2.09 (9.51)−5.40 (−9.12 to −1.68)0.005
Depressive complaints according to Hospital Anxiety and Depression Scale—Depression (0–21); mean (SD)
 Screening10.45 (2.67)9.97 (2.34)
 T17.67 (4.26)8.55 (3.81)
 T27.24 (4.62)9.40 (4.23)
 T1-screening−2.91 (3.67)−1.45 (3.06)−1.38 (−2.74 to −0.02)0.046
 T2-screening−3.24 (4.50)−0.38 (3.91)−2.62 (−4.41 to −0.83)0.005
Psychological distress (Brief Symptom Inventory) (0–212); mean (SD)
 Baseline40.79 (27.85)35.34 (25.47)
 T132.26 (30.84)36.89 (29.43)
 T232.19 (33.29)42.19 (33.78)
 T1–T0−9.71 (18.12)4.55 (17.33)−13.88 (−21.72 to −6.04)0.001
 T2–T0−9.32 (25.39)6.51(15.69)−15.69 (−25.11 to −6.26)0.001
  • * Measured from baseline until 12 months of follow-up.

  • Measured from baseline until 18 months of follow-up.

  • Dichotomous variable (no/yes) with N (%) indicating ‘yes.’

  • § β (95% CI) in case of continuous variable, RR (95% CI) in case of dichotomous variable and HR in case of time to onset of first sickness absence spell.

  • Scale range.